-+ 0.00%
-+ 0.00%
-+ 0.00%

NORTHSTRIVE BIOSCIENCES SIGNS DEFINITIVE LICENSE AGREEMENT FOR COMMERCIALIZATION OF EL-22 AND EL-32, A MYOSTATIN-ENGINEERED PROBIOTIC FOR MUSCLE PRESERVATION IN ANIMAL HEALTH

Reuters·02/11/2026 12:30:00

Please log in to view news